Literature DB >> 22806169

Cervical cancer in Africa.

Lynette Denny1, Rose Anorlu.   

Abstract

Cervical cancer is a relatively rare disease in countries that have instituted and maintained national screening programs, with call and recall of women at various intervals and built-in quality control with appropriate monitoring and evaluation. Unfortunately, this process has failed in most areas of the world where more than 80% of new cases of cervical cancer are diagnosed. Cervical cancer affects women in the prime of their lives causing premature and needless suffering and death in a critically important segment of the world's population, despite being one of the few cancers that can be prevented with simple testing. In the past 15 years innovative approaches to both primary and secondary prevention of cervical cancer have been subjected to a number of large scale, scientifically valid and applicable studies that have opened the way for new approaches. Treatment of cervical cancer in Africa is hampered by the lack of diagnostic and treatment facilities, lack of healthcare infrastructure and poor pathology services. Further, there is a significant brain drain of trained healthcare workers in Africa that exacerbates the problem. Cancer is becoming an increasingly important public health problem as more people live longer. It is time to develop programs for the prevention, early detection, treatment, and palliation of cancer sufferers in Africa. ©2012 AACR

Entities:  

Mesh:

Year:  2012        PMID: 22806169     DOI: 10.1158/1055-9965.EPI-12-0334

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  37 in total

1.  Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy.

Authors:  Eva Johanna Kantelhardt; Ulrike Moelle; Matthias Begoihn; Adamu Addissie; Pietro Trocchi; Bekuretsion Yonas; Petros Hezkiel; Andreas Stang; Christoph Thomssen; Dirk Vordermark; Tufa Gemechu; Yirgu Gebrehiwot; Tigeneh Wondemagegnehu; Abreha Aynalem; Assefa Mathewos
Journal:  Oncologist       Date:  2014-06-20

2.  Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.

Authors:  J Obel; J McKenzie; L E Buenconsejo-Lum; A M Durand; A Ekeroma; Y Souares; D Hoy; W Baravilala; S M Garland; S K Kjaer; A Roth
Journal:  Asian Pac J Cancer Prev       Date:  2015

3.  Experiences and unmet needs of women undergoing Pap smear cervical cancer screening: impact on uptake of cervical cancer screening in south eastern Nigeria.

Authors:  Chibuike O Chigbu; Azubuike K Onyebuchi; Chuma C Egbuji; Eusebus C Ezugwu
Journal:  J Cancer Educ       Date:  2015-03       Impact factor: 2.037

4.  Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.

Authors:  Andamlak Eskale Mebratie; Nurilign Abebe Moges; Belsity Temesgen Meselu; Misganaw Fikrie Melesse
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

5.  "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.

Authors:  Tram Kim Lam; Margaret Spitz; Sheri D Schully; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-15       Impact factor: 4.254

6.  Comparison of careHPV and hybrid capture 2 assays for detection of high-risk human Papillomavirus DNA in cervical samples from HIV-1-infected African women.

Authors:  Jean Ngou; Mahlape P Magooa; Clare Gilham; Florencia Djigma; Marie-Noelle Didelot; Helen Kelly; Albert Yonli; Bernard Sawadogo; David A Lewis; Sinead Delany-Moretlwe; Philippe Mayaud; Michel Segondy
Journal:  J Clin Microbiol       Date:  2013-10-09       Impact factor: 5.948

7.  Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia.

Authors:  Carla J Chibwesha; Brigitte Frett; Katundu Katundu; Allen C Bateman; Aaron Shibemba; Sharon Kapambwe; Mulindi H Mwanahamuntu; Susan Banda; Chalwa Hamusimbi; Pascal Polepole; Groesbeck P Parham
Journal:  J Low Genit Tract Dis       Date:  2016-07       Impact factor: 1.925

Review 8.  Optimal management of cervical cancer in HIV-positive patients: a systematic review.

Authors:  Atara Ntekim; Oladapo Campbell; Dietrich Rothenbacher
Journal:  Cancer Med       Date:  2015-07-01       Impact factor: 4.452

9.  Predictors of default from follow-up care in a cervical cancer screening program using direct visual inspection in south-western Nigeria.

Authors:  Oliver Chukwujekwu Ezechi; Karen Odberg Petterson; Titilola A Gbajabiamila; Ifeoma Eugenia Idigbe; Olutunmike Kuyoro; Innocent Achaya Otobo Ujah; Per Olof Ostergren
Journal:  BMC Health Serv Res       Date:  2014-03-31       Impact factor: 2.655

10.  Reproductive and maternal health in the post-2015 era: cervical cancer must be a priority.

Authors:  Ruby Singhrao; Megan Huchko; Gavin Yamey
Journal:  PLoS Med       Date:  2013-08-13       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.